BIO logo

BIO

Bio-Rad Laboratories Inc. Class A

$316.70
+$13.09(+4.31%)
52
Overall
50
Value
54
Tech
--
Quality
Market Cap
$8.30B
Volume
126.65K
52W Range
$211.43 - $373.69
Target Price
$341.25

Company Overview

Mkt Cap$8.30BPrice$316.70
Volume126.65KChange+4.31%
P/E Ratio-4.5Open$303.63
Revenue$2.6BPrev Close$303.61
Net Income$-1.8B52W Range$211.43 - $373.69
Div YieldN/ATarget$341.25
Overall52Value50
Quality--Technical54

No chart data available

About Bio-Rad Laboratories Inc. Class A

Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials, such as cells, proteins, and nucleic acids used in biopharmaceutical manufacturing, quality control process, food safety, and science education applications. It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, and transfusion and physician office laboratories. The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers. Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.

Sector: Healthcare
Industry: Diagnostics & Research

Latest News

Sabio Holdings to Release Q3 2025 Financial Results

The latest announcement is out from Sabio Holdings ( ($TSE:SBIO) ). Sabio Holdings announced it will release its unaudited fiscal Q3 2025 financial...

TipRanks Canadian Auto-Generated Newsdesk2 days ago

Zenas BioPharma Reports Q3 2025 Financial Results

TipRanks Auto-Generated Newsdesk9 days ago

Jade Biosciences Advances Autoimmune Therapies

TipRanks Auto-Generated Newsdesk9 days ago

Fortress Biotech’s Earnings Call Highlights EMROSI Success

TipRanks Auto-Generated Newsdesk9 days ago

BioVaxys Announces Debt Settlement to Strengthen Financial Position

TipRanks Canadian Auto-Generated Newsdesk9 days ago
ABCD
1SymbolPriceChangeVol
2BIO$316.70+4.3%126.65K
3
4
5
6

Get Bio-Rad Laboratories Inc. Class A Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.